Inventor
OUYANG JING
US13 patents
⚠️ This page may combine multiple inventors who share the name “OUYANG JING”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
DANA FARBER CANCER INST INC
5 patentsUS10844126B2Nov 24, 2020
Anti-galectin-1 (GAL1) monoclonal antibodies and fragments thereof for neutralizing GAL1
DANA FARBER CANCER INST INC1 citations70
US10519238B2Dec 31, 2019
Anti-galectin-1 monoclonal antibodies and fragments thereof
DANA FARBER CANCER INST INC2 citations70
US10456465B2Oct 29, 2019
Compositions, kits, and methods for the diagnosis prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1
DANA FARBER CANCER INST INC1 citations69
US11673956B2Jun 13, 2023
Anti-galectin-1 (Gal1) monoclonal antibodies and fragments thereof for neutralizing Gal1
DANA FARBER CANCER INST INC0 citations60
US11723972B2Aug 15, 2023
Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1
DANA FARBER CANCER INST INC0 citations58
SHIPP MARGARET A
3 patentsUS8968740B2Mar 3, 2015
Compositions, kits, and methods for the diagnosis, prognosis, monitoring, treatment and modulation of post-transplant lymphoproliferative disorders and hypoxia associated angiogenesis disorders using galectin-1
SHIPP MARGARET A7 citations79
US9206427B2Dec 8, 2015
Compositions, kits, and methods for the modulation of immune responses using galectin-1
SHIPP MARGARET A4 citations63
US9939428B2Apr 10, 2018
Compositions, kits, and methods for the diagnosis, prognosis, and monitoring of immune disorders using galectin-1
SHIPP MARGARET A0 citations32